{"transactions":[{"id":1759886,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":1,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":2,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":3,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":4,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-16T20:51:41.000Z","date":"2023-10-13","kind":"sale","planned":false,"acquired":false,"shares":1076841,"price":0.1038,"value":111776.0958,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001760460-23-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000176046023000008/primary_doc.xml","form_type":"4"}},{"id":1841130,"issuer":{"id":86860,"kind":"organization","name":"MariaDB plc","symbol":"NONE"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2023-06-30T18:16:43.000Z","date":"2023-06-29","kind":"grant","planned":false,"acquired":true,"shares":182291,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award that will fully vest upon the earlier of (i) the one-year anniversary of the grant date and (ii) the day immediately prior to the Company's annual meeting of shareholders that next occurs after the grant date."}],"balance_after":2659568,"source":{"system":"sec-edgar","filing":"0001225208-23-007045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000122520823007045/doc4.xml","form_type":"4"}},{"id":1860576,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-06-09T16:10:38.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":false,"shares":14607,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was approved by the Compensation Committee of the Board of Directors of Bellerophon Therapeutics, Inc., on February 10, 2023, contingent upon stockholder approval of an amendment to the Company's 2015 Equity Incentive Plan under which the options were granted, which was approved by stockholders on June 7, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on June 7, 2024."}],"balance_after":14607,"derivative":{"exercise_price":0.8264,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":14607},"source":{"system":"sec-edgar","filing":"0001104659-23-069905","document":"tm2318251-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000110465923069905/tm2318251-3_4seq1.xml","form_type":"4"}},{"id":1864010,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":1,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":2,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":3,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":4,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-07T21:21:26.000Z","date":"2023-06-07","kind":"sale","planned":false,"acquired":false,"shares":134421,"price":0.83,"value":111569.43,"ownership":{"direct":true},"balance_after":1076841,"source":{"system":"sec-edgar","filing":"0001760460-23-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000176046023000006/primary_doc.xml","form_type":"4"}},{"id":1884752,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":1,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":2,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":3,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-19T20:55:49.000Z","date":"2023-05-18","kind":"sale","planned":false,"acquired":false,"shares":560000,"price":9.46,"value":5297600.0,"ownership":{"direct":true},"balance_after":1211262,"source":{"system":"sec-edgar","filing":"0001760460-23-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000176046023000003/primary_doc.xml","form_type":"4"}},{"id":1893574,"issuer":{"id":86860,"kind":"organization","name":"MariaDB plc","symbol":"NONE"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2023-05-15T20:30:50.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":48342,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award that vests in full on the day prior to the Company's 2023 annual meeting of shareholders."}],"balance_after":2477277,"source":{"system":"sec-edgar","filing":"0001225208-23-005921","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000122520823005921/doc4.xml","form_type":"4"}},{"id":2016491,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2023-02-14T16:45:56.000Z","date":"2023-02-10","kind":"grant","acquired":true,"shares":29000,"price":1.52,"value":44080.0,"ownership":{"direct":true},"balance_after":29000,"derivative":{"exercise_price":1.52,"exercise_date":"2024-02-10","expiration_date":"2033-02-10","underlying":"Common Stock","underlying_shares":29000},"source":{"system":"sec-edgar","filing":"0001415889-23-002456","document":"form4-02142023_040222.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000141588923002456/form4-02142023_040222.xml","form_type":"4"}},{"id":2081846,"issuer":{"id":121474,"kind":"organization","name":"Angel Pond Holdings Corp","symbol":"POND"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":121475,"kind":"person","name":"Xie Shihuang","position":2,"cik":"0001848676","reported_name":"Xie Shihuang","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121476,"kind":"organization","name":"Lionyet International Ltd.","position":3,"cik":"0001848059","reported_name":"Lionyet International Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Ordinary Shares","published_at":"2022-12-19T18:13:02.000Z","date":"2022-12-16","kind":"other","acquired":false,"shares":6637870,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Disposed of pursuant to the business combination agreement dated January 31, 2022 (the \"BCA\") between MariaDB plc (formerly named Mangomill plc, the \"Company\") and Angel Pond Holdings Corp. (\"APHC\") in exchange for ordinary shares, nominal value $0.01 per share, of the Company (the \"Combined Company Ordinary Shares\")."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to the business combination agreement dated January 31, 2022 (the \"BCA\") between MariaDB plc (formerly named Mangomill plc, the \"Company\") and Angel Pond Holdings Corp. (\"APHC\") in exchange for ordinary shares, nominal value $0.01 per share, of the Company (the \"Combined Company Ordinary Shares\")."},{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed of pursuant to the business combination agreement dated January 31, 2022 (the \"BCA\") between MariaDB plc (formerly named Mangomill plc, the \"Company\") and Angel Pond Holdings Corp. (\"APHC\") in exchange for ordinary shares, nominal value $0.01 per share, of the Company (the \"Combined Company Ordinary Shares\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-253990), as amended, under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer would automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of, or immediately following, the issuer's initial business combination, on a one-for-one basis, subject to certain adjustments, and have no expiration date. On December 16, 2022, each share of Class B common stock, par value $0.0001 per share, of APHC owned by the reporting persons were cancelled and converted into the right to receive one Combined Company Ordinary Shares, subject to the terms and conditions of the BCA."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-253990), as amended, under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer would automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of, or immediately following, the issuer's initial business combination, on a one-for-one basis, subject to certain adjustments, and have no expiration date. On December 16, 2022, each share of Class B common stock, par value $0.0001 per share, of APHC owned by the reporting persons were cancelled and converted into the right to receive one Combined Company Ordinary Shares, subject to the terms and conditions of the BCA."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-253990), as amended, under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer would automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of, or immediately following, the issuer's initial business combination, on a one-for-one basis, subject to certain adjustments, and have no expiration date. On December 16, 2022, each share of Class B common stock, par value $0.0001 per share, of APHC owned by the reporting persons were cancelled and converted into the right to receive one Combined Company Ordinary Shares, subject to the terms and conditions of the BCA."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Disposed of pursuant to the business combination agreement dated January 31, 2022 (the \"BCA\") between MariaDB plc (formerly named Mangomill plc, the \"Company\") and Angel Pond Holdings Corp. (\"APHC\") in exchange for ordinary shares, nominal value $0.01 per share, of the Company (the \"Combined Company Ordinary Shares\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shihuang Xie is the director of Lionyet International Ltd. Lionyet International Ltd and Theodore Wang are the co-managing members of Angel Pond Partners LLC and together exercised voting and investment power with respect to the Class B ordinary shares, par value $0.0001 per share, held by Angel Pond Partners LLC. The shares beneficially owned by Angel Pond Partners LLC may have been deemed to be beneficially owned by Mr. Xie, Lionyet International Ltd. and Theodore Wang."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":6637870},"source":{"system":"sec-edgar","filing":"0000899243-22-039040","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842430/000089924322039040/doc4.xml","form_type":"4"}},{"id":2081722,"issuer":{"id":86860,"kind":"organization","name":"MariaDB plc","symbol":"NONE"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-12-19T17:41:54.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":2428935,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 16, 2022, MariaDB plc, an Irish public limited company (formerly named Mangomill plc, the \"Issuer\") announced the completion of the business combination between Angel Pond Holdings Corporation, a Cayman Islands exempted company (\"APHC\") and MariaDB Corporation Ab, a Finnish private limited liability company (\"MariaDB\") with and into the Issuer, with Issuer continuing as the surviving corporation (the \"Business Combination\"), pursuant to a business combination agreement, dated as of January 31, 2022, by and among the Issuer, APHC, MariaDB, and Meridian MergerSub Inc., a Cayman Islands exempted company and wholly owned subsidiary of the Issuer (the \"Merger Agreement\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with the Business Combination, each share of Class B common stock, par value $0.0001 per share, of APHC owned by the reporting person was cancelled and converted into the right to receive one ordinary share, nominal value $0.01 per share, of the Issuer, subject to the terms and conditions of the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 16, 2022, MariaDB plc, an Irish public limited company (formerly named Mangomill plc, the \"Issuer\") announced the completion of the business combination between Angel Pond Holdings Corporation, a Cayman Islands exempted company (\"APHC\") and MariaDB Corporation Ab, a Finnish private limited liability company (\"MariaDB\") with and into the Issuer, with Issuer continuing as the surviving corporation (the \"Business Combination\"), pursuant to a business combination agreement, dated as of January 31, 2022, by and among the Issuer, APHC, MariaDB, and Meridian MergerSub Inc., a Cayman Islands exempted company and wholly owned subsidiary of the Issuer (the \"Merger Agreement\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the Business Combination, each share of Class B common stock, par value $0.0001 per share, of APHC owned by the reporting person was cancelled and converted into the right to receive one ordinary share, nominal value $0.01 per share, of the Issuer, subject to the terms and conditions of the Merger Agreement."}],"balance_after":2428935,"source":{"system":"sec-edgar","filing":"0000899243-22-039032","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000089924322039032/doc4.xml","form_type":"4"}},{"id":2417003,"issuer":{"id":121474,"kind":"organization","name":"Angel Pond Holdings Corp","symbol":"POND"},"owners":[{"id":121475,"kind":"person","name":"Xie Shihuang","position":1,"cik":"0001848676","reported_name":"Xie Shihuang","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121476,"kind":"organization","name":"Lionyet International Ltd.","position":2,"cik":"0001848059","reported_name":"Lionyet International Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":3,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Ordinary Shares","published_at":"2022-02-02T09:10:47.000Z","date":"2022-01-28","kind":"other","acquired":false,"shares":0,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On January 28, 2022, Angel Pond Partners LLC, Lionyet International Ltd., Theodore Wang and Shihuang Xie agreed to sell 10,000 Class B Ordinary Shares, par value $0.0001 per share (the \"Class B Shares\"), of Angel Pond Holdings Corp. (the \"Issuer\") pursuant to a forward purchase agreement. As described in the issuer's registration statement on Form S-1 (File No. 333-253990), as amended, under the heading \"Principal Shareholders,\" the obligation to deliver the Class B Shares pursuant to the prepaid forwards is triggered by the consummation of an initial business combination. Until the transfers are consummated, Angel Pond Partners LLC will retain total voting and disposition control over the founder shares subject to the forward purchase agreements, subject to the future delivery obligations."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"(Continued from Footnote 1) As described in the issuer's registration statement on Form S-1 (File No. 333-253990), as amended, under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of, or immediately following, the issuer's initial business combination, on a one-for-one basis, subject to certain adjustments, and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 28, 2022, Angel Pond Partners LLC, Lionyet International Ltd., Theodore Wang and Shihuang Xie agreed to sell 10,000 Class B Ordinary Shares, par value $0.0001 per share (the \"Class B Shares\"), of Angel Pond Holdings Corp. (the \"Issuer\") pursuant to a forward purchase agreement. As described in the issuer's registration statement on Form S-1 (File No. 333-253990), as amended, under the heading \"Principal Shareholders,\" the obligation to deliver the Class B Shares pursuant to the prepaid forwards is triggered by the consummation of an initial business combination. Until the transfers are consummated, Angel Pond Partners LLC will retain total voting and disposition control over the founder shares subject to the forward purchase agreements, subject to the future delivery obligations."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from Footnote 1) As described in the issuer's registration statement on Form S-1 (File No. 333-253990), as amended, under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of, or immediately following, the issuer's initial business combination, on a one-for-one basis, subject to certain adjustments, and have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 28, 2022, Angel Pond Partners LLC, Lionyet International Ltd., Theodore Wang and Shihuang Xie agreed to sell 10,000 Class B Ordinary Shares, par value $0.0001 per share (the \"Class B Shares\"), of Angel Pond Holdings Corp. (the \"Issuer\") pursuant to a forward purchase agreement. As described in the issuer's registration statement on Form S-1 (File No. 333-253990), as amended, under the heading \"Principal Shareholders,\" the obligation to deliver the Class B Shares pursuant to the prepaid forwards is triggered by the consummation of an initial business combination. Until the transfers are consummated, Angel Pond Partners LLC will retain total voting and disposition control over the founder shares subject to the forward purchase agreements, subject to the future delivery obligations."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) As described in the issuer's registration statement on Form S-1 (File No. 333-253990), as amended, under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of, or immediately following, the issuer's initial business combination, on a one-for-one basis, subject to certain adjustments, and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 28, 2022, Angel Pond Partners LLC, Lionyet International Ltd., Theodore Wang and Shihuang Xie agreed to sell 10,000 Class B Ordinary Shares, par value $0.0001 per share (the \"Class B Shares\"), of Angel Pond Holdings Corp. (the \"Issuer\") pursuant to a forward purchase agreement. As described in the issuer's registration statement on Form S-1 (File No. 333-253990), as amended, under the heading \"Principal Shareholders,\" the obligation to deliver the Class B Shares pursuant to the prepaid forwards is triggered by the consummation of an initial business combination. Until the transfers are consummated, Angel Pond Partners LLC will retain total voting and disposition control over the founder shares subject to the forward purchase agreements, subject to the future delivery obligations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(Continued from Footnote 1) As described in the issuer's registration statement on Form S-1 (File No. 333-253990), as amended, under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of, or immediately following, the issuer's initial business combination, on a one-for-one basis, subject to certain adjustments, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On January 28, 2022, Angel Pond Partners LLC, Lionyet International Ltd., Theodore Wang and Shihuang Xie agreed to sell 10,000 Class B Ordinary Shares, par value $0.0001 per share (the \"Class B Shares\"), of Angel Pond Holdings Corp. (the \"Issuer\") pursuant to a forward purchase agreement. As described in the issuer's registration statement on Form S-1 (File No. 333-253990), as amended, under the heading \"Principal Shareholders,\" the obligation to deliver the Class B Shares pursuant to the prepaid forwards is triggered by the consummation of an initial business combination. Until the transfers are consummated, Angel Pond Partners LLC will retain total voting and disposition control over the founder shares subject to the forward purchase agreements, subject to the future delivery obligations."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"(Continued from Footnote 1) As described in the issuer's registration statement on Form S-1 (File No. 333-253990), as amended, under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of, or immediately following, the issuer's initial business combination, on a one-for-one basis, subject to certain adjustments, and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shihuang Xie is the director of Lionyet International Ltd. Lionyet International Ltd and Theodore Wang are the co-managing members of Angel Pond Partners LLC and together exercise voting and investment power with respect to the Class B ordinary shares held by Angel Pond Partners LLC. The shares beneficially owned by Angel Pond Partners LLC may also be deemed to be beneficially owned by Mr. Xie, Lionyet International Ltd. and Theodore Wang."}],"balance_after":6637870,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0000899243-22-004048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842430/000089924322004048/doc4.xml","form_type":"4"}},{"id":2449459,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2022-01-04T16:10:40.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":21828,"price":3.1,"value":67666.8,"ownership":{"direct":true},"balance_after":35634,"derivative":{"exercise_price":3.1,"exercise_date":"2022-12-31","expiration_date":"2031-12-31","underlying":"Common Stock","underlying_shares":21828},"source":{"system":"sec-edgar","filing":"0001415889-22-000190","document":"form4-01042022_040130.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000141588922000190/form4-01042022_040130.xml","form_type":"4"}},{"id":2639662,"issuer":{"id":121474,"kind":"organization","name":"Angel Pond Holdings Corp","symbol":"POND"},"owners":[{"id":121475,"kind":"person","name":"Xie Shihuang","position":1,"cik":"0001848676","reported_name":"Xie Shihuang","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121476,"kind":"organization","name":"Lionyet International Ltd.","position":2,"cik":"0001848059","reported_name":"Lionyet International Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":3,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Ordinary Shares","published_at":"2021-07-07T17:18:01.000Z","date":"2021-07-02","kind":"other","acquired":false,"shares":549630,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 2, 2021, Angel Pond Partners LLC (the \"Sponsor\") forfeited for no consideration 549,630  Class B Ordinary Shares, par value $0.0001 per share (the \"Class B Shares\"), of Angel Pond Holdings Corp. (the \"Issuer\") in connection with the partial exercise of the underwriters' over-allotment option. As described in the issuer's registration statement on Form S-1 (File No. 333-253990), as amended, under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of, or immediately following, the issuer's initial business combination, on a one-for-one basis, subject to certain adjustments, and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 2, 2021, Angel Pond Partners LLC (the \"Sponsor\") forfeited for no consideration 549,630  Class B Ordinary Shares, par value $0.0001 per share (the \"Class B Shares\"), of Angel Pond Holdings Corp. (the \"Issuer\") in connection with the partial exercise of the underwriters' over-allotment option. As described in the issuer's registration statement on Form S-1 (File No. 333-253990), as amended, under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of, or immediately following, the issuer's initial business combination, on a one-for-one basis, subject to certain adjustments, and have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 2, 2021, Angel Pond Partners LLC (the \"Sponsor\") forfeited for no consideration 549,630  Class B Ordinary Shares, par value $0.0001 per share (the \"Class B Shares\"), of Angel Pond Holdings Corp. (the \"Issuer\") in connection with the partial exercise of the underwriters' over-allotment option. As described in the issuer's registration statement on Form S-1 (File No. 333-253990), as amended, under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of, or immediately following, the issuer's initial business combination, on a one-for-one basis, subject to certain adjustments, and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 2, 2021, Angel Pond Partners LLC (the \"Sponsor\") forfeited for no consideration 549,630  Class B Ordinary Shares, par value $0.0001 per share (the \"Class B Shares\"), of Angel Pond Holdings Corp. (the \"Issuer\") in connection with the partial exercise of the underwriters' over-allotment option. As described in the issuer's registration statement on Form S-1 (File No. 333-253990), as amended, under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of, or immediately following, the issuer's initial business combination, on a one-for-one basis, subject to certain adjustments, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 2, 2021, Angel Pond Partners LLC (the \"Sponsor\") forfeited for no consideration 549,630  Class B Ordinary Shares, par value $0.0001 per share (the \"Class B Shares\"), of Angel Pond Holdings Corp. (the \"Issuer\") in connection with the partial exercise of the underwriters' over-allotment option. As described in the issuer's registration statement on Form S-1 (File No. 333-253990), as amended, under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of, or immediately following, the issuer's initial business combination, on a one-for-one basis, subject to certain adjustments, and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shihuang Xie is the director of Lionyet International Ltd. Lionyet International Ltd and Theodore Wang are the co-managing members of Angel Pond Partners LLC and together exercise voting and investment power with respect to the Class B ordinary shares held by Angel Pond Partners LLC. The shares beneficially owned by Angel Pond Partners LLC may also be deemed to be beneficially owned by Mr. Xie, Lionyet International Ltd. and Theodore Wang."}],"balance_after":6637870,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":549630},"source":{"system":"sec-edgar","filing":"0001209191-21-045864","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842430/000120919121045864/doc4.xml","form_type":"4"}},{"id":2677798,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":1,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":2,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":3,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":4,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":5,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-08T12:37:09.000Z","date":"2021-06-07","kind":"grant","acquired":true,"shares":8189,"price":4,"value":32756.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"1. These securities are held directly by Puissance Life Science Opportunities Fund VI and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Life Science Opportunities Fund VI; Puissance Capital Management (GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Life Science Opportunities Fund VI; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Persons each disclaim beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that any Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1771262,"source":{"system":"sec-edgar","filing":"0001760460-21-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000176046021000004/primary_doc.xml","form_type":"4"}},{"id":2703486,"issuer":{"id":121474,"kind":"organization","name":"Angel Pond Holdings Corp","symbol":"POND"},"owners":[{"id":121475,"kind":"person","name":"Xie Shihuang","position":1,"cik":"0001848676","reported_name":"Xie Shihuang","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121476,"kind":"organization","name":"Lionyet International Ltd.","position":2,"cik":"0001848059","reported_name":"Lionyet International Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":3,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Ordinary Shares","published_at":"2021-05-20T13:22:27.000Z","date":"2021-05-18","kind":"other","acquired":false,"shares":1437500,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 18, 2021, Angel Pond Partners LLC (the \"Sponsor\") forfeited for no consideration 1,437,500  Class B Ordinary Shares, par value $0.0001 per share (the \"Class B Shares\"), of Angel Pond Holdings Corp. (the \"Issuer\") in connection with a reduction of the number of shares issued in the Issuer's initial public offering. As described in the issuer's registration statement on Form S-1 (File No. 333-253990), as amended, under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of, or immediately following, the issuer's initial business combination, on a one-for-one basis, subject to certain adjustments, and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 18, 2021, Angel Pond Partners LLC (the \"Sponsor\") forfeited for no consideration 1,437,500  Class B Ordinary Shares, par value $0.0001 per share (the \"Class B Shares\"), of Angel Pond Holdings Corp. (the \"Issuer\") in connection with a reduction of the number of shares issued in the Issuer's initial public offering. As described in the issuer's registration statement on Form S-1 (File No. 333-253990), as amended, under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of, or immediately following, the issuer's initial business combination, on a one-for-one basis, subject to certain adjustments, and have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 18, 2021, Angel Pond Partners LLC (the \"Sponsor\") forfeited for no consideration 1,437,500  Class B Ordinary Shares, par value $0.0001 per share (the \"Class B Shares\"), of Angel Pond Holdings Corp. (the \"Issuer\") in connection with a reduction of the number of shares issued in the Issuer's initial public offering. As described in the issuer's registration statement on Form S-1 (File No. 333-253990), as amended, under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of, or immediately following, the issuer's initial business combination, on a one-for-one basis, subject to certain adjustments, and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 18, 2021, Angel Pond Partners LLC (the \"Sponsor\") forfeited for no consideration 1,437,500  Class B Ordinary Shares, par value $0.0001 per share (the \"Class B Shares\"), of Angel Pond Holdings Corp. (the \"Issuer\") in connection with a reduction of the number of shares issued in the Issuer's initial public offering. As described in the issuer's registration statement on Form S-1 (File No. 333-253990), as amended, under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of, or immediately following, the issuer's initial business combination, on a one-for-one basis, subject to certain adjustments, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On May 18, 2021, Angel Pond Partners LLC (the \"Sponsor\") forfeited for no consideration 1,437,500  Class B Ordinary Shares, par value $0.0001 per share (the \"Class B Shares\"), of Angel Pond Holdings Corp. (the \"Issuer\") in connection with a reduction of the number of shares issued in the Issuer's initial public offering. As described in the issuer's registration statement on Form S-1 (File No. 333-253990), as amended, under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of, or immediately following, the issuer's initial business combination, on a one-for-one basis, subject to certain adjustments, and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shihuang Xie is the director of Lionyet International Ltd. Lionyet International Ltd and Theodore Wang are the co-managing members of Angel Pond Partners LLC and together exercise voting and investment power with respect to the Class B ordinary shares held by Angel Pond Partners LLC. The shares beneficially owned by Angel Pond Partners LLC may also be deemed to be beneficially owned by Mr. Xie, Lionyet International Ltd. and Theodore Wang."}],"balance_after":7187500,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":1437500},"source":{"system":"sec-edgar","filing":"0001209191-21-034336","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842430/000120919121034336/doc4.xml","form_type":"4"}},{"id":2739700,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":1,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":2,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":3,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":4,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":5,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (Right to buy)","published_at":"2021-04-26T12:39:28.000Z","date":"2021-04-26","kind":"grant","acquired":true,"shares":304286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are held directly by Puissance Life Science Opportunities Fund VI and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Life Science Opportunities Fund VI; Puissance Capital Management (GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Life Science Opportunities Fund VI; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Persons each disclaim beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that any Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":685236,"derivative":{"exercise_price":18.63,"exercise_date":"2018-03-29","expiration_date":"2022-09-29","underlying":"Common Stock","underlying_shares":304286},"source":{"system":"sec-edgar","filing":"0001760460-21-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000176046021000002/primary_doc.xml","form_type":"4"}},{"id":2739699,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":1,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":2,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":3,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":4,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":5,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (Right to buy)","published_at":"2021-04-26T12:39:28.000Z","date":"2021-04-26","kind":"grant","acquired":true,"shares":380950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are held directly by Puissance Life Science Opportunities Fund VI and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Life Science Opportunities Fund VI; Puissance Capital Management (GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Life Science Opportunities Fund VI; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Persons each disclaim beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that any Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":380950,"derivative":{"exercise_price":12,"exercise_date":"2016-11-29","expiration_date":"2023-11-29","underlying":"Common Stock","underlying_shares":380950},"source":{"system":"sec-edgar","filing":"0001760460-21-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000176046021000002/primary_doc.xml","form_type":"4"}},{"id":2739698,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":1,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":2,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":3,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":4,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":5,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-04-26T12:39:28.000Z","date":"2021-04-26","kind":"grant","acquired":true,"shares":609231,"price":4,"value":2436924.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are held directly by Puissance Life Science Opportunities Fund VI and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Life Science Opportunities Fund VI; Puissance Capital Management (GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Life Science Opportunities Fund VI; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Persons each disclaim beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that any Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1763077,"source":{"system":"sec-edgar","filing":"0001760460-21-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000176046021000002/primary_doc.xml","form_type":"4"}},{"id":2983834,"issuer":{"id":4331,"kind":"organization","name":"ChronoScale Holdings Corp","symbol":"CHRN"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-12T16:07:36.000Z","date":"2020-11-10","kind":"other","acquired":false,"shares":744572,"ownership":{"direct":false,"nature":"By Puissance Cross-Border Opportunities II LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Puissance Cross-Border Opportunities II LLC made an in-kind distribution of an aggregate 744,572 shares of the Issuer's common stock to one of its limited partners in connection with the redemption of partnership interests."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Puissance Cross-Border Opportunities II LLC made an in-kind distribution of an aggregate 744,572 shares of the Issuer's common stock to one of its limited partners in connection with the redemption of partnership interests."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are held directly by Puissance Cross-Border Opportunities II LLC and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Cross Border Opportunities II LLC; Puissance Capital Management (GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Cross Border Opportunities II LLC; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":29828,"source":{"system":"sec-edgar","filing":"0001209191-20-057907","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000120919120057907/doc4.xml","form_type":"4"}},{"id":3032377,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-09-14T16:04:01.000Z","date":"2020-09-10","kind":"grant","acquired":true,"shares":6509,"price":10.12,"value":65871.08,"ownership":{"direct":true},"balance_after":13806,"derivative":{"exercise_price":10.12,"exercise_date":"2021-09-10","expiration_date":"2030-09-10","underlying":"Common Stock","underlying_shares":6509},"source":{"system":"sec-edgar","filing":"0001600132-20-000104","document":"wf-form4_160011382783695.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000160013220000104/wf-form4_160011382783695.xml","form_type":"4"}},{"id":3075601,"issuer":{"id":4331,"kind":"organization","name":"ChronoScale Holdings Corp","symbol":"CHRN"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":147615,"kind":"organization","name":"Puissance Cross-Border Opportunities II LLC","position":2,"cik":"0001717781","reported_name":"Puissance Cross-Border Opportunities II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":3,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-27T16:42:27.000Z","date":"2020-07-23","kind":"grant","acquired":true,"shares":7383,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The grant consists of RSUs that fully vest one year from the date of grant, or July 23, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"After taking into account the 1-for-15 reverse stock split effective March 24, 2020."}],"balance_after":9958,"source":{"system":"sec-edgar","filing":"0001209191-20-043737","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717781/000120919120043737/doc4.xml","form_type":"4"}},{"id":3116654,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T16:01:52.000Z","date":"2020-06-08","kind":"purchase","acquired":true,"shares":2600,"price":12.867,"value":33454.2,"ownership":{"direct":true},"balance_after":60913,"source":{"system":"sec-edgar","filing":"0001600132-20-000062","document":"wf-form4_159173289350800.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000160013220000062/wf-form4_159173289350800.xml","form_type":"4"}},{"id":3116653,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T16:01:52.000Z","date":"2020-06-05","kind":"purchase","acquired":true,"shares":4986,"price":12.724,"value":63441.864,"ownership":{"direct":true},"balance_after":58313,"source":{"system":"sec-edgar","filing":"0001600132-20-000062","document":"wf-form4_159173289350800.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000160013220000062/wf-form4_159173289350800.xml","form_type":"4"}},{"id":3137479,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":1,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":2,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":3,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":4,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":5,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-22T07:25:14.000Z","date":"2020-05-21","kind":"grant","acquired":true,"shares":1153846,"price":13,"value":14999998.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are held directly by Puissance Life Science Opportunities Fund VI and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Life Science Opportunities Fund VI; Puissance Capital Management (GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Life Science Opportunities Fund VI; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Persons each disclaim beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that any Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1153846,"source":{"system":"sec-edgar","filing":"0001760460-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000176046020000002/primary_doc.xml","form_type":"4"}},{"id":3173104,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":149751,"kind":"organization","name":"Puissance Cross-Border Opportunities III LLC","position":1,"cik":"0001718111","reported_name":"Puissance Cross-Border Opportunities III LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":2,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":3,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":4,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":5,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-04-20T10:47:45.000Z","date":"2020-04-17","kind":"other","acquired":false,"shares":553250,"ownership":{"direct":false,"nature":"By Puissance Cross-Border Opportunities III LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Puissance Cross-Border Opportunities III LLC made an in-kind distribution of an aggregate 553,250 shares of the Issuer's common stock to its limited partners in connection with the redemption of partnership interests."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Puissance Cross-Border Opportunities III LLC made an in-kind distribution of an aggregate 553,250 shares of the Issuer's common stock to its limited partners in connection with the redemption of partnership interests."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are held directly by Puissance Cross-Border Opportunities III LLC and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Cross Border Opportunities III LLC; Puissance Capital Management (GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Cross Border Opportunities III LLC; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001718111-20-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718111/000171811120000001/primary_doc.xml","form_type":"4"}},{"id":3227817,"issuer":{"id":4331,"kind":"organization","name":"ChronoScale Holdings Corp","symbol":"CHRN"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":147615,"kind":"organization","name":"Puissance Cross-Border Opportunities II LLC","position":2,"cik":"0001717781","reported_name":"Puissance Cross-Border Opportunities II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":3,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-03-04T20:42:33.000Z","date":"2020-03-02","kind":"other","acquired":false,"shares":8918898,"ownership":{"direct":false,"nature":"By Puissance Cross-Border Opportunities II LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Puissance Cross-Border Opportunities II LLC made an in-kind distribution of an aggregate 8,918,898 shares of the Issuer's common stock to one of its limited partners in connection with the redemption of partnership interests."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Puissance Cross-Border Opportunities II LLC made an in-kind distribution of an aggregate 8,918,898 shares of the Issuer's common stock to one of its limited partners in connection with the redemption of partnership interests."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are held directly by Puissance Cross-Border Opportunities II LLC and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Cross Border Opportunities II LLC; Puissance Capital Management (GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Cross Border Opportunities II LLC; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":11616000,"source":{"system":"sec-edgar","filing":"0001717781-20-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717781/000171778120000001/primary_doc.xml","form_type":"4"}},{"id":3306512,"issuer":{"id":4331,"kind":"organization","name":"ChronoScale Holdings Corp","symbol":"CHRN"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":147615,"kind":"organization","name":"Puissance Cross-Border Opportunities II LLC","position":2,"cik":"0001717781","reported_name":"Puissance Cross-Border Opportunities II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":3,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-01-21T20:58:11.000Z","date":"2020-01-16","kind":"grant","acquired":true,"shares":136496,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in 12 equal monthly installments beginning on the one-month anniversary of July 1, 2019."}],"balance_after":136496,"derivative":{"exercise_price":0.38,"expiration_date":"2030-01-16","underlying":"Common Stock","underlying_shares":136496},"source":{"system":"sec-edgar","filing":"0001209191-20-004378","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1717781/000120919120004378/doc4.xml","form_type":"4"}},{"id":3306511,"issuer":{"id":4331,"kind":"organization","name":"ChronoScale Holdings Corp","symbol":"CHRN"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":147615,"kind":"organization","name":"Puissance Cross-Border Opportunities II LLC","position":2,"cik":"0001717781","reported_name":"Puissance Cross-Border Opportunities II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":3,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-21T20:58:11.000Z","date":"2020-01-16","kind":"grant","acquired":true,"shares":19445,"price":0.45,"value":8750.25,"ownership":{"direct":true},"balance_after":38624,"source":{"system":"sec-edgar","filing":"0001209191-20-004378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717781/000120919120004378/doc4.xml","form_type":"4"}},{"id":3345394,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":153197,"kind":"organization","name":"Puissance Cross-Border Opportunities V LLC","position":1,"cik":"0001733439","reported_name":"Puissance Cross-Border Opportunities V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153198,"kind":"organization","name":"Puissance Cross-Border Opportunities IV LLC","position":2,"cik":"0001718140","reported_name":"Puissance Cross-Border Opportunities IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":3,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":4,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":6,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-11T10:47:42.000Z","date":"2019-12-09","kind":"sale","acquired":false,"shares":340134,"price":2.92,"value":993191.28,"ownership":{"direct":false,"nature":"By funds"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Puissance Cross-Border Opportunities IV LLC made an in-kind distribution of 176,992 shares of common stock. Puissance Cross-Border Opportunities V LLC made an in-kind distribution of 163,142 shares of common stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Consists of: 76,048 Shares directly owned by Puissance Cross-Border Opportunities V LLC."}],"balance_after":76048,"source":{"system":"sec-edgar","filing":"0001733439-19-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1733439/000173343919000001/primary_doc.xml","form_type":"4"}},{"id":3345393,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":153197,"kind":"organization","name":"Puissance Cross-Border Opportunities V LLC","position":1,"cik":"0001733439","reported_name":"Puissance Cross-Border Opportunities V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153198,"kind":"organization","name":"Puissance Cross-Border Opportunities IV LLC","position":2,"cik":"0001718140","reported_name":"Puissance Cross-Border Opportunities IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":3,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":4,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":6,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-11T10:47:42.000Z","date":"2019-12-05","kind":"sale","acquired":false,"shares":43996,"price":3.05,"value":134187.8,"ownership":{"direct":false,"nature":"By funds"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Puissance Cross-Border Opportunities V LLC made an in-kind distribution of 43,996 shares of common stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Consists of: 239,190 Shares directly owned by Puissance Cross-Border Opportunities V LLC; 176,992 Shares directly owned Puissance Cross-Border Opportunities IV LLC."}],"balance_after":416182,"source":{"system":"sec-edgar","filing":"0001733439-19-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1733439/000173343919000001/primary_doc.xml","form_type":"4"}},{"id":3360053,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-11-25T16:52:44.000Z","date":"2019-11-25","kind":"purchase","acquired":true,"shares":7193,"price":0.3856,"value":2773.6208,"ownership":{"direct":true},"balance_after":592922,"source":{"system":"sec-edgar","filing":"0001600132-19-000164","document":"wf-form4_157471874347219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000160013219000164/wf-form4_157471874347219.xml","form_type":"4"}},{"id":3360052,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-11-25T16:52:44.000Z","date":"2019-11-22","kind":"purchase","acquired":true,"shares":1050,"price":0.3748,"value":393.54,"ownership":{"direct":true},"balance_after":585729,"source":{"system":"sec-edgar","filing":"0001600132-19-000164","document":"wf-form4_157471874347219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000160013219000164/wf-form4_157471874347219.xml","form_type":"4"}},{"id":3360051,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-11-25T16:52:44.000Z","date":"2019-11-21","kind":"purchase","acquired":true,"shares":200,"price":0.37,"value":74.0,"ownership":{"direct":true},"balance_after":584679,"source":{"system":"sec-edgar","filing":"0001600132-19-000164","document":"wf-form4_157471874347219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000160013219000164/wf-form4_157471874347219.xml","form_type":"4"}},{"id":3404520,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-09-30T16:54:44.000Z","date":"2019-09-26","kind":"grant","acquired":true,"shares":46266,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":109482,"derivative":{"exercise_price":0.5,"exercise_date":"2020-09-26","expiration_date":"2029-09-26","underlying":"Common Stock","underlying_shares":46266},"source":{"system":"sec-edgar","filing":"0001600132-19-000136","document":"wf-form4_156987686289140.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000160013219000136/wf-form4_156987686289140.xml","form_type":"4"}},{"id":3489708,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-06-14T11:46:56.000Z","date":"2019-06-12","kind":"purchase","acquired":true,"shares":50000,"price":0.6381,"value":31905.0,"ownership":{"direct":true},"balance_after":584479,"source":{"system":"sec-edgar","filing":"0001600132-19-000097","document":"wf-form4_156052720172568.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000160013219000097/wf-form4_156052720172568.xml","form_type":"4"}},{"id":3511911,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-24T09:30:54.000Z","date":"2019-05-22","kind":"purchase","acquired":true,"shares":27500,"price":0.6012,"value":16533.0,"ownership":{"direct":true},"balance_after":534479,"source":{"system":"sec-edgar","filing":"0001600132-19-000091","document":"wf-form4_155870463818500.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000160013219000091/wf-form4_155870463818500.xml","form_type":"4"}},{"id":3515416,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-22T11:15:08.000Z","date":"2019-05-21","kind":"purchase","acquired":true,"shares":43280,"price":0.6093,"value":26370.504,"ownership":{"direct":true},"balance_after":506979,"source":{"system":"sec-edgar","filing":"0001600132-19-000086","document":"wf-form4_155853809255361.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000160013219000086/wf-form4_155853809255361.xml","form_type":"4"}},{"id":3686828,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-01-25T16:22:25.000Z","date":"2019-01-25","kind":"purchase","acquired":true,"shares":450000,"price":0.7,"value":315000.0,"ownership":{"direct":true},"balance_after":463699,"source":{"system":"sec-edgar","filing":"0001600132-19-000044","document":"wf-form4_154845132884181.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000160013219000044/wf-form4_154845132884181.xml","form_type":"4"}},{"id":3709212,"issuer":{"id":111118,"kind":"organization","name":"ViewRay, Inc.","symbol":"VRAY"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-03T20:20:06.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":18668,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The reported securities are RSUs that entitle the Reporting Person to receive one share of Common Stock per RSU upon vesting. All of these RSUs shall vest on January 2, 2020 (the one-year anniversary of the grant date), subject to the Reporting Person remaining a service provider through such date."}],"balance_after":34117,"source":{"system":"sec-edgar","filing":"0000950103-19-000200","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000095010319000200/ownership.xml","form_type":"4"}},{"id":3709211,"issuer":{"id":111118,"kind":"organization","name":"ViewRay, Inc.","symbol":"VRAY"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-03T20:20:06.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":7305,"price":6.16,"value":44998.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are DSUs that entitle the Reporting Person to receive one share of Common Stock per DSU upon the earliest of (i) the Reporting Person's termination of service from the Issuer's board of directors, (ii) a Change of Control of the Issuer as defined in the Issuer's 2015 Equity Incentive Award Plan or (iii) January 2, 2029 (the tenth anniversary of the grant date). 1/12th of these DSUs shall vest on the last day of each calendar month beginning on January 31, 2019 such that 100% of the DSUs will be vested on December 31, 2019, subject to the Reporting Person remaining a service provider through each such vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These DSUs were issued to the reporting person pursuant to ViewRay Inc.'s Non-Employee Director Compensation Policy in lieu of retainer and committee service fees of $45,000."}],"balance_after":15449,"source":{"system":"sec-edgar","filing":"0000950103-19-000200","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000095010319000200/ownership.xml","form_type":"4"}},{"id":3719120,"issuer":{"id":111118,"kind":"organization","name":"ViewRay, Inc.","symbol":"VRAY"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-12-26T21:50:30.000Z","date":"2018-12-21","kind":"grant","acquired":true,"shares":19116,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares subject to the option had vested and were exercisable as of December 2018."}],"balance_after":19116,"derivative":{"exercise_price":5.21,"expiration_date":"2028-12-21","underlying":"Common Stock","underlying_shares":19116},"source":{"system":"sec-edgar","filing":"0000950103-18-015068","document":"dp100069_4-wang.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000095010318015068/dp100069_4-wang.xml","form_type":"4"}},{"id":3745921,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":153197,"kind":"organization","name":"Puissance Cross-Border Opportunities V LLC","position":1,"cik":"0001733439","reported_name":"Puissance Cross-Border Opportunities V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153198,"kind":"organization","name":"Puissance Cross-Border Opportunities IV LLC","position":2,"cik":"0001718140","reported_name":"Puissance Cross-Border Opportunities IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":3,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":6,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":7,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-03T10:14:33.000Z","date":"2018-11-29","kind":"sale","acquired":false,"shares":4326,"price":1.21,"value":5234.46,"ownership":{"direct":false,"nature":"By funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The purchase and sale of 4,326 shares of Common Stock were under the fund Puissance Life Science Opportunities Fund VI."}],"balance_after":4601768,"source":{"system":"sec-edgar","filing":"0001733439-18-000016","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000173343918000016/primary_doc.xml","form_type":"4/A","original_submission_date":"2018-12-03"}},{"id":3745920,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":153197,"kind":"organization","name":"Puissance Cross-Border Opportunities V LLC","position":1,"cik":"0001733439","reported_name":"Puissance Cross-Border Opportunities V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153198,"kind":"organization","name":"Puissance Cross-Border Opportunities IV LLC","position":2,"cik":"0001718140","reported_name":"Puissance Cross-Border Opportunities IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":3,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":6,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":7,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-03T10:14:33.000Z","date":"2018-11-29","kind":"purchase","acquired":true,"shares":4326,"price":1.13,"value":4888.38,"ownership":{"direct":false,"nature":"By funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The purchase and sale of 4,326 shares of Common Stock were under the fund Puissance Life Science Opportunities Fund VI."}],"balance_after":4606094,"source":{"system":"sec-edgar","filing":"0001733439-18-000016","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000173343918000016/primary_doc.xml","form_type":"4/A","original_submission_date":"2018-12-03"}},{"id":3745919,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":153197,"kind":"organization","name":"Puissance Cross-Border Opportunities V LLC","position":1,"cik":"0001733439","reported_name":"Puissance Cross-Border Opportunities V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153198,"kind":"organization","name":"Puissance Cross-Border Opportunities IV LLC","position":2,"cik":"0001718140","reported_name":"Puissance Cross-Border Opportunities IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":3,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":6,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":7,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-03T09:39:59.000Z","date":"2018-11-29","kind":"sale","acquired":true,"shares":4326,"price":1.21,"value":5234.46,"ownership":{"direct":false,"nature":"By funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The purchase and sale of 4,326 shares of Common Stock were under the fund Puissance Life Science Opportunities Fund VI."}],"balance_after":4601768,"source":{"system":"sec-edgar","filing":"0001733439-18-000015","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000173343918000015/primary_doc.xml","form_type":"4"}},{"id":3745918,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":153197,"kind":"organization","name":"Puissance Cross-Border Opportunities V LLC","position":1,"cik":"0001733439","reported_name":"Puissance Cross-Border Opportunities V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153198,"kind":"organization","name":"Puissance Cross-Border Opportunities IV LLC","position":2,"cik":"0001718140","reported_name":"Puissance Cross-Border Opportunities IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":3,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":6,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":7,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-03T09:39:59.000Z","date":"2018-11-29","kind":"purchase","acquired":true,"shares":4326,"price":1.13,"value":4888.38,"ownership":{"direct":false,"nature":"By funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The purchase and sale of 4,326 shares of Common Stock were under the fund Puissance Life Science Opportunities Fund VI."}],"balance_after":4606094,"source":{"system":"sec-edgar","filing":"0001733439-18-000015","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000173343918000015/primary_doc.xml","form_type":"4"}},{"id":3850900,"issuer":{"id":4331,"kind":"organization","name":"ChronoScale Holdings Corp","symbol":"CHRN"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":147615,"kind":"organization","name":"Puissance Cross-Border Opportunities II LLC","position":2,"cik":"0001717781","reported_name":"Puissance Cross-Border Opportunities II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":3,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-08-07T21:05:35.000Z","date":"2018-08-03","kind":"grant","acquired":true,"shares":41000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in 12 equal monthly installments beginning on the one-month anniversary of June 7, 2018."}],"balance_after":41000,"derivative":{"exercise_price":1.79,"expiration_date":"2028-08-03","underlying":"Common Stock","underlying_shares":41000},"source":{"system":"sec-edgar","filing":"0001209191-18-045772","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1717781/000120919118045772/doc4.xml","form_type":"4"}},{"id":3850899,"issuer":{"id":4331,"kind":"organization","name":"ChronoScale Holdings Corp","symbol":"CHRN"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":147615,"kind":"organization","name":"Puissance Cross-Border Opportunities II LLC","position":2,"cik":"0001717781","reported_name":"Puissance Cross-Border Opportunities II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":3,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-07T21:05:35.000Z","date":"2018-08-03","kind":"grant","acquired":true,"shares":19179,"price":1.79,"value":34330.41,"ownership":{"direct":true},"balance_after":19179,"source":{"system":"sec-edgar","filing":"0001209191-18-045772","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717781/000120919118045772/doc4.xml","form_type":"4"}},{"id":3853359,"issuer":{"id":111118,"kind":"organization","name":"ViewRay, Inc.","symbol":"VRAY"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-03T17:02:26.000Z","date":"2018-08-02","kind":"grant","acquired":true,"shares":1928,"price":8.18,"value":15771.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued to the reporting person pursuant to ViewRay, Inc.'s Non-Employee Director Compensation Policy in lieu of retainer and committee service fees of $15,778."}],"balance_after":8144,"source":{"system":"sec-edgar","filing":"0000950103-18-009419","document":"dp94310_4-wang.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000095010318009419/dp94310_4-wang.xml","form_type":"4"}},{"id":3872762,"issuer":{"id":111118,"kind":"organization","name":"ViewRay, Inc.","symbol":"VRAY"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-05T17:40:30.000Z","date":"2018-07-02","kind":"grant","acquired":true,"shares":2808,"price":7.12,"value":19992.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"1/6th of these shares shall vest and become exercisable on the last day of each calendar month beginning on July 31, 2018, such that 100% of the shares will be vested on December 31, 2018, subject to the Reporting Person remaining a service provider through each such vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were issued to the reporting person pursuant to ViewRay, Inc.'s Non-Employee Director Compensation Policy in lieu of retainer and committee service fees of $20,000."}],"balance_after":6216,"source":{"system":"sec-edgar","filing":"0000950103-18-008366","document":"dp93196_4-wang.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000095010318008366/dp93196_4-wang.xml","form_type":"4"}},{"id":3884144,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-25T16:32:09.000Z","date":"2018-06-21","kind":"grant","acquired":true,"shares":13699,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13699,"source":{"system":"sec-edgar","filing":"0001600132-18-000098","document":"wf-form4_152995871323145.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000160013218000098/wf-form4_152995871323145.xml","form_type":"4"}},{"id":3895586,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2018-06-13T20:05:48.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders."}],"balance_after":15000,"derivative":{"exercise_price":2.7,"expiration_date":"2028-06-12","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-18-037613","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000120919118037613/doc4.xml","form_type":"4"}},{"id":3901773,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-07T16:44:53.000Z","date":"2018-06-05","kind":"grant","acquired":true,"shares":38216,"price":2.27,"value":86750.32,"ownership":{"direct":true},"balance_after":63216,"derivative":{"exercise_price":2.27,"exercise_date":"2019-06-05","expiration_date":"2028-06-04","underlying":"Common Stock","underlying_shares":38216},"source":{"system":"sec-edgar","filing":"0001600132-18-000066","document":"wf-form4_152840427506208.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000160013218000066/wf-form4_152840427506208.xml","form_type":"4"}},{"id":3956187,"issuer":{"id":111118,"kind":"organization","name":"ViewRay, Inc.","symbol":"VRAY"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-04-26T17:24:56.000Z","date":"2017-11-15","kind":"grant","acquired":true,"shares":18459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/12 of the shares subject to the option vested and became exercisable on each monthly anniversary measured from June 19, 2017, such that 100% of the shares subject to the option will fully vest on June 19, 2018."}],"balance_after":18459,"derivative":{"exercise_price":8.02,"expiration_date":"2027-11-15","underlying":"Common Stock","underlying_shares":18459},"source":{"system":"sec-edgar","filing":"0000950103-18-005219","document":"dp89954_4-wang.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000095010318005219/dp89954_4-wang.xml","form_type":"4"}},{"id":3956186,"issuer":{"id":111118,"kind":"organization","name":"ViewRay, Inc.","symbol":"VRAY"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-26T17:24:56.000Z","date":"2017-11-15","kind":"grant","acquired":true,"shares":3408,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units (\"RSUs\"). The reported securities are fully vested RSUs that entitle the Reporting Person to receive one share of Common Stock per RSU upon the earlier of (i) the Reporting Person's termination of service from the Issuer's board of directors or (ii) a Change of Control of the Issuer as defined in the Issuer's 2015 Equity Incentive Award Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of RSUs."}],"balance_after":3408,"source":{"system":"sec-edgar","filing":"0000950103-18-005219","document":"dp89954_4-wang.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000095010318005219/dp89954_4-wang.xml","form_type":"4"}},{"id":3967010,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2018-04-09T20:53:15.000Z","date":"2018-04-06","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest and become exercisable in three equal annual installments commencing on the first anniversary of the grant date set forth in column 3 above."}],"balance_after":25000,"derivative":{"exercise_price":2.55,"expiration_date":"2028-04-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-18-024455","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000120919118024455/doc4.xml","form_type":"4"}},{"id":4131877,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-12-14T16:34:53.000Z","date":"2017-12-12","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in three equal annual installments over a three-year period from the date of Dr. Wang's board appointment on November 27, 2017."}],"balance_after":25000,"derivative":{"exercise_price":2.25,"expiration_date":"2027-12-11","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001600132-17-000136","document":"wf-form4_151328727965670.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000160013217000136/wf-form4_151328727965670.xml","form_type":"4"}},{"id":4481952,"issuer":{"id":111118,"kind":"organization","name":"ViewRay, Inc.","symbol":"VRAY"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-01-25T17:57:58.000Z","date":"2017-01-24","kind":"grant","acquired":true,"shares":19556,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 12 monthly installments on each monthly anniversary of January 24, 2017 until such shares subject to the option have become fully vested and exercisable."}],"balance_after":19556,"derivative":{"exercise_price":5.3,"expiration_date":"2027-01-24","underlying":"Common Stock","underlying_shares":19556},"source":{"system":"sec-edgar","filing":"0001140361-17-002908","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694061/000114036117002908/doc1.xml","form_type":"4"}}]}